# Single-Cell Multi-Omics Profiling of Human Septal Myectomy Tissue: Toward Precision Medicine in Obstructive Hypertrophic Cardiomyopathy

## TL;DR

This paper reviews how single-cell and spatial multi-omics technologies are improving understanding of hypertrophic cardiomyopathy and paving the way for precision medicine.

## Contribution

The paper provides a synthesis of recent single-cell and spatial transcriptomic studies in HCM, highlighting their potential for precision medicine.

## Key findings

- Single-cell and spatial multi-omics reveal HCM as a complex, multicellular disease.
- These technologies identify cell-specific transcriptional programs and signaling pathways.
- Findings suggest new strategies for precision medicine in obstructive HCM.

## Abstract

Hypertrophic cardiomyopathy (HCM) is an inherited cardiac disorder most commonly caused by pathogenic variants in sarcomeric genes, yet many patients remain genotype-negative and the mechanisms linking genetic alterations to disease pathology are not fully understood. Traditional bulk analyses have provided limited insight into the cellular and molecular changes that drive disease progression. Recent advances in single-cell and spatial multi-omics technologies now allow detailed characterization of cell type-specific transcriptional programs, signaling pathways, and tissue remodeling within the human myocardium. These approaches have begun to redefine HCM as a complex, multicellular disease rather than a purely sarcomeric disorder. This review summarizes current single-cell and spatial transcriptomic studies of human septal myectomy tissue, outlines their major findings and limitations, and discusses how these data may inform the development of precision medicine strategies in obstructive HCM.